Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe site version label was updated to Revision: v3.5.0 with the previous Revision: v3.4.3 removed.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change does not modify study details, eligibility criteria, or page functionality.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 entry and the government funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a Show glossary option and updated QC-related metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or renamed.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision tag updated to v3.3.4; prior tag v3.3.3 is no longer displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.